Publicaties

Joosten EAG, Wamel A, Joosten EAG, Dijkstra BAG.  2020.  Achtergronddocument Handreiking voor GHB behandeling.

Markus W, Hornsveld HK, Burk WJ, van Oene GH de Weert, Becker ES, DeJong CAJ.  2020.  Addiction-Focused Eye Movement Desensitization and Reprocessing Therapy as an Adjunct to Regular Outpatient Treatment for Alcohol Use Disorder: Results From a Randomized Clinical Trial.. Alcohol Clin Exp Res. 44(1):272-283.

Dijkstra B.A.G., Malcontent J., van Dongen A..  2019.  Aanpak GHB-problematiek binnen en buiten de regio - de Etten-Leurse aanpak.

van Duijvenbode N, VanDerNagel JEL, Didden R.  2019.  Alcohol (mis)use in individuals with mild to borderline intellectual disability. Neuroscience of alcohol.

VanDerNagel JEL, van Duijvenbode N, Didden R.  2019.  Assessment of alcohol use disorder and alcohol-related offending behaviour. What works for offenders with intellectual and developmental disabilities: Theory, research and practice.

Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, A von Borries KL, Schene AH, Van der Ven AJAM, Schellekens AFA.  2019.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One. 14(2):e0207970.

Van Kampen-Dunkerbeck A, Cousijn J, Engel C, Rinck M, Dijkstra BAG.  2019.  Attentional bias, craving and cannabis use in an inpatient sample of adolescents and young adults diagnosed with cannabis use disorder: The moderating role of cognitive control. Addict Behav. 100:106126.

Otte RA, Verbrugge CAG, Dijkstra BAG.  2016.  Aanbevelingen voor ketenzorg bij GHB gerelateerde problemen. NISPA GHB Onderzoek.

Ayu AParawita, Iskandar S, Siste K, DeJong CA, Schellekens A.  2016.  Addiction training for health professionals as an antidote to the addiction health burden in Indonesia.. Addiction. 111(8):1498-9.

Markus W.  2016.  Are addiction-related memories malleable by working memory competition? Transient effects on memory vividness and nicotine craving in a randomized lab experiment. Behavioral Therapy and Experimental Psychiatry. (52):83-91.

Blanco-Hinojo L, Pujol J, Harrison BJ, Macià D, Batalla A, Nogué S, Torrens M, Farré M, Deus J, Martin-Santos R.  2016.  Attenuated frontal and sensory inputs to the basal ganglia in cannabis users.. Addict Biol.

DeJong CA, Luycks L.  2015.  Addiction medicine training in the Netherlands. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. . XII

Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.  2015.  Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.. Transl Psychiatry. 5:e626.

Kok T, de Haan HA, van der Meer M, Najavits L, DeJong CA.  2015.  Assessing traumatic experiences in screening for PTSD in substance use disorder patients: What is the gain in addition to PTSD symptoms? Psychiatry Res. 226(1):328-32.

López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A.  2015.  Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 45(6):1121-33.

de Haan HA, van der Palen J, Wijdeveld AGM, Buitelaar JK, DeJong CA.  2014.  Alexithymia in patients with substance use disorders: State or trait? Psychiatry Res.

Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Farré M et al..  2012.  Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.. Curr Pharm Des. 18(32):4966-79.

Carpentier PJ.  2012.  Addiction and the role of childhood externalising disorders. Sociale Wetenschappen. Ph. D.:182.

Carpentier PJ, Knapen LJM, Van Gogh MT, Buitelaar JK, DeJong CA.  2012.  Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.. J Addict Dis. 31(1):45-59.

de Haan HA, Joosten EAG, Wijdeveld AGM, Boswinkel PB, van der Palen J, DeJong CA.  2012.  Alexithymia is not a stable personality trait in patients with substance use disorders.. Psychiatry Res. 198(1):123-9.

Postel MG, de Haan HA, Ter Huurne ED, van der Palen J, Becker ES, DeJong CA.  2011.  Attrition in web-based treatment for problem drinkers.. J Med Internet Res. 13(4):e117.

Schellekens A, de Bruijn ERA, van Lankveld CAA, Hulstijn W, Buitelaar JK, DeJong CA, Verkes RJ.  2010.  Alcohol dependence and anxiety increase error-related brain activity.. Addiction. 105(11):1928-34.

Batalla A, Vera M, Torra M, Parellada E.  2010.  Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.. J Clin Psychopharmacol. 30(1):92-4.

DeJong CA, Galyuk TM, de Backer G, Beers E, Loonen AJ.  2009.  Abuse of quetiapine: two addicted patients with borderline personality disorder. Nederlands Tijdschrift Geneeskunde. 153(14)

DeJong CA, Van de Wetering BJM.  2009.  Addiction medicine is an attractive field for young physicians-a call for a European initiative for the training in addiction medicine. Addiction. 7(104):9.